Iron sucrose with or without recombinant erythropoietin for treatment of moderate and severe anemia in late third trimester

Elmantwe, Ashraf

doi:10.21608/egyfs.2017.19222

Search citation statements

Order By: Relevance

Paper Sections

Select...

Introduction1

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2022

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

(1 citation statement)

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Preterm birth rates (28.2%), preeclampsia (31.2%), and maternal sepsis are all up due to anemia. 4 40-60% of maternal mortalities from heart failure, bleeding, infection, and pre-eclampsia are directly or indirectly attributable to iron deficiency anemia. 5 In areas where anemia incidence is more than 40% in women and adolescents, the WHO established a worldwide guideline in 2016 suggesting daily oral iron intake (60mg iron) for 12 weeks.…”

Section: Introductionmentioning

confidence: 99%

Intravenous Iron Sucrose versus Intramuscular Iron Sorbitol in management of iron deficiency anemia during pregnancy

Hamed

Ahmed²,

Sultan³

2022

Al-Azhar International Medical Journal

View full text Add to dashboard Cite

Background:The greatest prevalent nutrient shortage in pregnant women across the globe is iron deficiency anemia (IDA). Maternal anemia continues to significantly increase neonatal morbidity and death, and there is worry over the elevated incidence of iron and other micronutrient deficiencies among pregnant women in poor nations. Aim of the work:To examine the effectiveness and safety of intramuscular iron sorbitol citric acid complex and intravenous iron sucrose in the treating of iron deficiency anemia (IDA) in gestation.

show abstract

Section: Introductionmentioning

confidence: 99%